Skip to main content
Top
Published in: Graefe's Archive for Clinical and Experimental Ophthalmology 3/2016

01-03-2016 | Retinal Disorders

Influence of macular oedema on the measurement of macular pigment optical density

Authors: Simone Thiele, Franziska Georgia Rauscher, Peter Wiedemann, Jens Dawczynski

Published in: Graefe's Archive for Clinical and Experimental Ophthalmology | Issue 3/2016

Login to get access

Abstract

Introduction

The purpose of this study was to determine macular pigment optical density (MPOD) in patients with macular degeneration as well as in patients with non-proliferative diabetic retinopathy.

Methods

Fifty-one phakic patients with either age-related macular degeneration (60 eyes of 30 patients; average age, 70.9 years) or non-proliferative diabetic retinopathy (42 eyes of 21 patients; average age, 61.7 years) were included in this cross-sectional study. Within the groups, patients were divided into those suffering from macular oedema and those with no oedema. An intra-subject comparison between eyes was carried out in both groups. Data were investigated on the basis of the coefficient of determination (R 2). Macular pigment optical density was measured by fundus reflectometry using the one-wavelength reflection method (Visucam 500; Carl Zeiss Meditec AG, Jena, Germany), in conformity with the method described by Schweitzer et al. (2010). We evaluated the maximum optical density in the measurement area (max OD) and the average optical density across the reference area in the measurement area (mean OD). Specifically, the influence of macular oedema on macular pigment optical density was examined. The subsequent measurement of retinal thickness was carried out by spectral-domain optical coherence tomography (Spectralis SD-OCT, Heidelberg Engineering GmbH, Heidelberg, Germany).

Results

The current study included two groups. The first group consisted of patients with non-proliferative diabetic retinopathy, as follows: no macular oedema on either side (max OD: R 2 = 43.2 %, p = 0.16; mean OD: R 2 = 68.7 %, p = 0.04); one-sided macular oedema (max OD: R2 = 16 %, p = 0.60; mean OD: R2 = 100 %, p = 0.04); or macular oedema in both eyes (max OD: R2 = 79.7 %, p < 0.01; mean OD: R2 = 81.4 %, p < 0.01). The second group comprised patients with age-related macular degeneration (AMD), as follows: non-exudative changes on both sides (max OD: R2 = 64.0 %, p = 0.20; mean OD: R 2 = 16 %, p = 0.60); one-sided exudative macular changes (max OD: R 2 = 50.6 %, p < 0.01; mean OD: R 2 = 20.8 %, p = 0.04); or exudative macular degeneration on both sides (max OD: 3 R 2 = 6.0 %, p = 0.29; mean OD: R 2= 81.0 %, p = 0.04). The data available presented a correlation of MPOD values of both eyes of an individual within the groups investigated. In this respect, the data of the partner eyes within the group of patients with diabetic retinopathy were more highly correlated with each other than the values of both eyes of patients suffering from age-related macular degeneration.

Conclusions

The present study showed that macular oedema did not seem to have an influence on a valid measurement of MPOD by one-wavelength fundus reflectometry. Thus, meaningful data could also be obtained on patients with exudative retinal changes.
Literature
1.
go back to reference Buzzi F (1782) Nuove sperienze fatte sull’occhio umano. Opuscoli Scetti Sulle Scienze e. Sulle Arti 5:87 Buzzi F (1782) Nuove sperienze fatte sull’occhio umano. Opuscoli Scetti Sulle Scienze e. Sulle Arti 5:87
3.
go back to reference Bone RA, Landrum JT, Tarsis SL (1985) Preliminary identification of the human macular pigment. Vision Res 25:1531–1535CrossRefPubMed Bone RA, Landrum JT, Tarsis SL (1985) Preliminary identification of the human macular pigment. Vision Res 25:1531–1535CrossRefPubMed
4.
go back to reference Beatty S, Murray IJ, Henson DB, Carden D, Koh H, Boulton ME (2001) Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population. Invest Ophthalmol Vis Sci 42:439–446PubMed Beatty S, Murray IJ, Henson DB, Carden D, Koh H, Boulton ME (2001) Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population. Invest Ophthalmol Vis Sci 42:439–446PubMed
5.
go back to reference Dawczynski J, Jentsch S, Schweitzer D, Hammer M, Strobel J (2012) Änderung von Makulapigment und Drusenmorphologie unter Luteinsupplementation. Klin Monatsbl Augenheilkd 229:69–71CrossRefPubMed Dawczynski J, Jentsch S, Schweitzer D, Hammer M, Strobel J (2012) Änderung von Makulapigment und Drusenmorphologie unter Luteinsupplementation. Klin Monatsbl Augenheilkd 229:69–71CrossRefPubMed
6.
go back to reference Koo E, Neuringer M, SanGiovanni JP (2014) Macular xanthophylls, lipoprotein-related genes, and age-related macular degeneration. Am J Clin Nutr pii: ajcn.071563 Koo E, Neuringer M, SanGiovanni JP (2014) Macular xanthophylls, lipoprotein-related genes, and age-related macular degeneration. Am J Clin Nutr pii: ajcn.071563
7.
go back to reference Komar B, Rauscher FG, Wiedemann R, Dawczynski J (2014) Macular pigment optical density measurements by one-wavelength reflection photometry-influence of cataract surgery on the measurement results. Graefes Arch Clin Exp Ophthalmol 252(11):1717–1727CrossRefPubMed Komar B, Rauscher FG, Wiedemann R, Dawczynski J (2014) Macular pigment optical density measurements by one-wavelength reflection photometry-influence of cataract surgery on the measurement results. Graefes Arch Clin Exp Ophthalmol 252(11):1717–1727CrossRefPubMed
8.
go back to reference Murray IJ, Hassanali B, Carden D (2013) Macular pigment in ophthalmic practice; a survey. Graefes Arch Clin Exp Ophthalmol 251(10):2355–2362CrossRefPubMed Murray IJ, Hassanali B, Carden D (2013) Macular pigment in ophthalmic practice; a survey. Graefes Arch Clin Exp Ophthalmol 251(10):2355–2362CrossRefPubMed
9.
go back to reference Wolf-Schnurrbusch UE, Röösli N, Weyermann E, Heldner MR, Höhne K, Wolf S (2007) Ethnic differences in macular pigment optical density and distribution. Invest Ophthalmol Vis Sci 48:3783–3787CrossRefPubMed Wolf-Schnurrbusch UE, Röösli N, Weyermann E, Heldner MR, Höhne K, Wolf S (2007) Ethnic differences in macular pigment optical density and distribution. Invest Ophthalmol Vis Sci 48:3783–3787CrossRefPubMed
10.
go back to reference Lima VC, Rosen RB, Maia M, Prata TS, Dorairaj S, Farah ME, Sallum J (2010) Macular pigment optical density measured by dual-wavelength autofluorescence imaging in diabetic and nondiabetic patients: a comparative study. Invest Ophthalmol Vis Sci 51:5840–5845CrossRefPubMed Lima VC, Rosen RB, Maia M, Prata TS, Dorairaj S, Farah ME, Sallum J (2010) Macular pigment optical density measured by dual-wavelength autofluorescence imaging in diabetic and nondiabetic patients: a comparative study. Invest Ophthalmol Vis Sci 51:5840–5845CrossRefPubMed
11.
go back to reference LaRowe TL, Mares JA, Snodderly DM, Klein ML, Wooten BR, Chappell R, CAREDS Macular Pigment Study Group (2008) Macular pigment optical density and age-related maculopathy in the Carotenoids in Age-Related Eye Disease Study. An Ancillary study of the women's health initiative. Ophthalmology 115:876–883CrossRefPubMed LaRowe TL, Mares JA, Snodderly DM, Klein ML, Wooten BR, Chappell R, CAREDS Macular Pigment Study Group (2008) Macular pigment optical density and age-related maculopathy in the Carotenoids in Age-Related Eye Disease Study. An Ancillary study of the women's health initiative. Ophthalmology 115:876–883CrossRefPubMed
12.
go back to reference Howells O, Eperjesi F, Bartlett H (2011) Measuring macular pigment optical density in vivo: a review of techniques. Graefes Arch Clin Exp Ophthalmol 249:315–347CrossRefPubMed Howells O, Eperjesi F, Bartlett H (2011) Measuring macular pigment optical density in vivo: a review of techniques. Graefes Arch Clin Exp Ophthalmol 249:315–347CrossRefPubMed
13.
go back to reference Bernstein PS, Zhao DY, Wintch SW, Ermakov IV, McClane RW, Gellermann W (2002) Resonance Raman measurement of macular carotenoids in normal subjects and in age-related macular degeneration patients. Ophthalmology 109:1780–1787PubMedCentralCrossRefPubMed Bernstein PS, Zhao DY, Wintch SW, Ermakov IV, McClane RW, Gellermann W (2002) Resonance Raman measurement of macular carotenoids in normal subjects and in age-related macular degeneration patients. Ophthalmology 109:1780–1787PubMedCentralCrossRefPubMed
14.
go back to reference Stringham JM, Hammond BR Jr (2005) Dietary lutein and zeaxanthin: possible effects on visual function. Nutr Rev 63:59–64CrossRefPubMed Stringham JM, Hammond BR Jr (2005) Dietary lutein and zeaxanthin: possible effects on visual function. Nutr Rev 63:59–64CrossRefPubMed
15.
go back to reference Krinsky NI, Landrum JT, Bone RA (2003) Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye. Annu Rev Nutr 23:171–201CrossRefPubMed Krinsky NI, Landrum JT, Bone RA (2003) Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye. Annu Rev Nutr 23:171–201CrossRefPubMed
16.
go back to reference Hammond BR Jr, Wooten BR, Curran-Celentano J (2001) Carotenoids in the retina and lens: possible acute and chronic effects on human visual performance. Arch Biochem Biophys 385:41–46CrossRefPubMed Hammond BR Jr, Wooten BR, Curran-Celentano J (2001) Carotenoids in the retina and lens: possible acute and chronic effects on human visual performance. Arch Biochem Biophys 385:41–46CrossRefPubMed
18.
go back to reference Snodderly DM (1995) Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins. Am J Clin Nutr 62:1448S–1461SPubMed Snodderly DM (1995) Evidence for protection against age-related macular degeneration by carotenoids and antioxidant vitamins. Am J Clin Nutr 62:1448S–1461SPubMed
19.
go back to reference Kirchfeld K (1982) Carotenoid pigments: their possible role in protecting against photooxidation in eyes and photoreceptor cells. Proc R Soc Lond B Biol Sci 216:71–85CrossRef Kirchfeld K (1982) Carotenoid pigments: their possible role in protecting against photooxidation in eyes and photoreceptor cells. Proc R Soc Lond B Biol Sci 216:71–85CrossRef
20.
go back to reference Foote CS, Chang YC, Denny RW (1970) Chemistry of singlet oxygen. X Carotenoid quenching parallels biological protection. J Am Chem Soc 92:5216–5218CrossRefPubMed Foote CS, Chang YC, Denny RW (1970) Chemistry of singlet oxygen. X Carotenoid quenching parallels biological protection. J Am Chem Soc 92:5216–5218CrossRefPubMed
21.
go back to reference Malinow MR, Feeney-Burns L, Peterson LH, Klein ML, Neuringer M (1980) Diet-related macular anomalies in monkeys. Invest Ophthalmol Vis Sci 19:857–863PubMed Malinow MR, Feeney-Burns L, Peterson LH, Klein ML, Neuringer M (1980) Diet-related macular anomalies in monkeys. Invest Ophthalmol Vis Sci 19:857–863PubMed
22.
go back to reference Bernstein PS, Delori FC, Richer S, van Kuijk FJ, Wenzel AJ (2010) The value of measurement of macular carotenoid pigment optical densities and distributions in age-related macular degeneration and other retinal disorders. Vision Res 50:716–728PubMedCentralCrossRefPubMed Bernstein PS, Delori FC, Richer S, van Kuijk FJ, Wenzel AJ (2010) The value of measurement of macular carotenoid pigment optical densities and distributions in age-related macular degeneration and other retinal disorders. Vision Res 50:716–728PubMedCentralCrossRefPubMed
23.
24.
go back to reference Hammond BR Jr, Fuld K (1992) Interocular differences in macular pigment density. Invest Ophthalmol Vis Sci 33:350–355PubMed Hammond BR Jr, Fuld K (1992) Interocular differences in macular pigment density. Invest Ophthalmol Vis Sci 33:350–355PubMed
25.
go back to reference Dawczynski J, Schweitzer D, Lang GE (2011) Möglichkeiten der objektiven Messung der optischen Dichte der Makula. Klin Monatsbl Augenheilkd 228:57–61CrossRefPubMed Dawczynski J, Schweitzer D, Lang GE (2011) Möglichkeiten der objektiven Messung der optischen Dichte der Makula. Klin Monatsbl Augenheilkd 228:57–61CrossRefPubMed
26.
go back to reference Wolf S (2006) Macular pigment measurements: which method should we use? Graefes Arch Clin Exp Ophthalmol 244:1562–1564CrossRefPubMed Wolf S (2006) Macular pigment measurements: which method should we use? Graefes Arch Clin Exp Ophthalmol 244:1562–1564CrossRefPubMed
27.
go back to reference Schweitzer D, Jentsch S, Dawczynski J, Hammer M, Wolf-Schnurrbusch UE, Wolf S (2010) Simple and objective method for routine detection of the macular pigment xanthophylls. J Biomed Opt 15:061714CrossRefPubMed Schweitzer D, Jentsch S, Dawczynski J, Hammer M, Wolf-Schnurrbusch UE, Wolf S (2010) Simple and objective method for routine detection of the macular pigment xanthophylls. J Biomed Opt 15:061714CrossRefPubMed
28.
go back to reference Hammer M, Schweitzer D, Leistritz L (2003) Bestimmung der Konzentrationsverteilung des Makulapigmentes aus Reflexions- und Fluoreszenzaufnahmen. Ophthalmologe 100:611–617CrossRefPubMed Hammer M, Schweitzer D, Leistritz L (2003) Bestimmung der Konzentrationsverteilung des Makulapigmentes aus Reflexions- und Fluoreszenzaufnahmen. Ophthalmologe 100:611–617CrossRefPubMed
29.
go back to reference Wolf-Schnurrbusch UE, Ceklic L, Brinkmann CK, Iliev ME, Frey M, Rothenbuehler SP, Enzmann V, Wolf S (2009) Macular thickness measurements in healthy eyes using six different optical coherence tomography instruments. Invest Ophthalmol Vis Sci 50:3432–3437CrossRefPubMed Wolf-Schnurrbusch UE, Ceklic L, Brinkmann CK, Iliev ME, Frey M, Rothenbuehler SP, Enzmann V, Wolf S (2009) Macular thickness measurements in healthy eyes using six different optical coherence tomography instruments. Invest Ophthalmol Vis Sci 50:3432–3437CrossRefPubMed
30.
go back to reference Massin P, Erginay A, Haouchine B, Mehidi AB, Paques M, Gaudric A (2002) Retinal thickness in healthy and diabetic subjects measured using optical coherence tomography mapping software. Eur J Ophthalmol 2:102–108 Massin P, Erginay A, Haouchine B, Mehidi AB, Paques M, Gaudric A (2002) Retinal thickness in healthy and diabetic subjects measured using optical coherence tomography mapping software. Eur J Ophthalmol 2:102–108
32.
go back to reference Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY, MARINA Study Group (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355(14):1419–1431CrossRefPubMed Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY, MARINA Study Group (2006) Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 355(14):1419–1431CrossRefPubMed
33.
go back to reference Dietze H (2008) Die optometrische Untersuchung. Georg Thieme Verlag, StuttgartCrossRef Dietze H (2008) Die optometrische Untersuchung. Georg Thieme Verlag, StuttgartCrossRef
34.
go back to reference Collins JF, Augustin AJ (1997) Masse und optische Daten. In: Collins JF, Augustin AJ (eds) Augenheilkunde, 1st edn. Springer, BerlinCrossRef Collins JF, Augustin AJ (1997) Masse und optische Daten. In: Collins JF, Augustin AJ (eds) Augenheilkunde, 1st edn. Springer, BerlinCrossRef
35.
go back to reference Bühl A (2014) SPSS 22: Einführung in die moderne Datenanalyse. Pearson Deutschland GmbH, Berlin Bühl A (2014) SPSS 22: Einführung in die moderne Datenanalyse. Pearson Deutschland GmbH, Berlin
36.
go back to reference Hammond BR Jr, Wooten BR, Snodderly DM (1997) Individual variations in the spatial profile of human macular pigment. J Opt Soc Am A Opt Image Sci Vis 14:1187–1196CrossRefPubMed Hammond BR Jr, Wooten BR, Snodderly DM (1997) Individual variations in the spatial profile of human macular pigment. J Opt Soc Am A Opt Image Sci Vis 14:1187–1196CrossRefPubMed
37.
go back to reference Berendschot TT, van Norren D (2006) Macular pigment shows ringlike structures. Invest Ophthalmol Vis Sci 47:709–714CrossRefPubMed Berendschot TT, van Norren D (2006) Macular pigment shows ringlike structures. Invest Ophthalmol Vis Sci 47:709–714CrossRefPubMed
38.
go back to reference Robson AG, Moreland JD, Pauleikhoff D, Morrissey T, Holder GE, Fitzke FW, Bird AC, van Kuijk FJ (2003) Macular pigment optical density and distribution: comparison of fundus autofluorescence with minimum motion photometry. Vision Res 43:1765–1775CrossRefPubMed Robson AG, Moreland JD, Pauleikhoff D, Morrissey T, Holder GE, Fitzke FW, Bird AC, van Kuijk FJ (2003) Macular pigment optical density and distribution: comparison of fundus autofluorescence with minimum motion photometry. Vision Res 43:1765–1775CrossRefPubMed
39.
go back to reference Bone RA, Landrum JT, Mayne ST, Gomez CM, Tibor SE, Twaroska EE (2001) Macular pigment in donor eyes with and without AMD: a case–control study. Invest Ophthalmol Vis Sci 42:235–240PubMed Bone RA, Landrum JT, Mayne ST, Gomez CM, Tibor SE, Twaroska EE (2001) Macular pigment in donor eyes with and without AMD: a case–control study. Invest Ophthalmol Vis Sci 42:235–240PubMed
40.
go back to reference Trieschmann M, Spital G, Lommatzsch A, van Kuijk E, Fitzke F, Bird AC, Pauleikhoff D (2003) Macular pigment: quantitative analysis on autofluorescence images. Graefes Arch Clin Exp Ophthalmol 241:1006–1012CrossRefPubMed Trieschmann M, Spital G, Lommatzsch A, van Kuijk E, Fitzke F, Bird AC, Pauleikhoff D (2003) Macular pigment: quantitative analysis on autofluorescence images. Graefes Arch Clin Exp Ophthalmol 241:1006–1012CrossRefPubMed
41.
go back to reference Ciulla TA, Hammond BR Jr (2004) Macular pigment optical density and aging, assessed in the normal elderly and those with cataracts and age-related macular degeneration. Am J Ophthalmol 138:582–587CrossRefPubMed Ciulla TA, Hammond BR Jr (2004) Macular pigment optical density and aging, assessed in the normal elderly and those with cataracts and age-related macular degeneration. Am J Ophthalmol 138:582–587CrossRefPubMed
42.
go back to reference Tsika C, Tsilimbaris MK, Makridaki M, Kontadakis G, Plainis S, Moschandreas J (2011) Assessment of macular pigment optical density (MPOD) in patients with unilateral wet age-related macular degeneration (AMD). Acta Ophthalmol 89:573–578CrossRef Tsika C, Tsilimbaris MK, Makridaki M, Kontadakis G, Plainis S, Moschandreas J (2011) Assessment of macular pigment optical density (MPOD) in patients with unilateral wet age-related macular degeneration (AMD). Acta Ophthalmol 89:573–578CrossRef
43.
go back to reference Delori FC, Goger DG, Hammond BR, Snodderly DM, Burns SA (2001) Macular pigment optical density measured by autofluorescence spectrometry: comparison with reflectometry and heterochromatic flicker photometry. J Opt Soc Am A Opt Image Sci Vis 18:1212–1230CrossRefPubMed Delori FC, Goger DG, Hammond BR, Snodderly DM, Burns SA (2001) Macular pigment optical density measured by autofluorescence spectrometry: comparison with reflectometry and heterochromatic flicker photometry. J Opt Soc Am A Opt Image Sci Vis 18:1212–1230CrossRefPubMed
44.
go back to reference Pipis A, Touliou E, Augustin AJ (2013) Macular pigment optical density in a Central European population. Ophthalmic Surg Lasers Imageing Retina 44:260–267CrossRef Pipis A, Touliou E, Augustin AJ (2013) Macular pigment optical density in a Central European population. Ophthalmic Surg Lasers Imageing Retina 44:260–267CrossRef
45.
go back to reference Mellerio J, Ahmadi-Lari S, van Kuijk F, Pauleikhoff D, Bird A, Marshall J (2002) A portable instrument for measuring macular pigment with central fixation. Curr Eye Res 25:37–47CrossRefPubMed Mellerio J, Ahmadi-Lari S, van Kuijk F, Pauleikhoff D, Bird A, Marshall J (2002) A portable instrument for measuring macular pigment with central fixation. Curr Eye Res 25:37–47CrossRefPubMed
46.
go back to reference Davies NP, Morland AB (2002) Color matching in diabetes: optical density of the crystalline lens and macular pigments. Invest Ophthalmol Vis Sci 43:281–289PubMed Davies NP, Morland AB (2002) Color matching in diabetes: optical density of the crystalline lens and macular pigments. Invest Ophthalmol Vis Sci 43:281–289PubMed
47.
go back to reference Mares JA, LaRowe TL, Snodderly DM, Moeller SM, Gruber MJ, Klein ML, Wooten BR, Johnson EJ, Chappell RJ, CAREDS Macular Pigment Study Group and Investigators (2006) Predictors of optical density of lutein and zeaxanthin in retinas of older women in the Carotenoids in Age-Related Eye Disease Study, an ancillary study of the Women's Health Initiative. Am J Clin Nutr 84:1107–1122PubMed Mares JA, LaRowe TL, Snodderly DM, Moeller SM, Gruber MJ, Klein ML, Wooten BR, Johnson EJ, Chappell RJ, CAREDS Macular Pigment Study Group and Investigators (2006) Predictors of optical density of lutein and zeaxanthin in retinas of older women in the Carotenoids in Age-Related Eye Disease Study, an ancillary study of the Women's Health Initiative. Am J Clin Nutr 84:1107–1122PubMed
49.
go back to reference Sakanishi Y, Awano M, Mizota A, Tanaka M, Murakami A, Ohnuma K (2012) Age-related changes in spectral transmittance of the human crystalline lens in situ. Ophthalmologica 228:174–180CrossRefPubMed Sakanishi Y, Awano M, Mizota A, Tanaka M, Murakami A, Ohnuma K (2012) Age-related changes in spectral transmittance of the human crystalline lens in situ. Ophthalmologica 228:174–180CrossRefPubMed
50.
go back to reference Artigas JM, Felipe A, Navea A, Fandiño A, Artigas C (2012) Spectral transmission of the human crystalline lens in adult and elderly persons: color and total transmission of visible light. Invest Ophthalmol Vis Sci 53:4076–4084CrossRefPubMed Artigas JM, Felipe A, Navea A, Fandiño A, Artigas C (2012) Spectral transmission of the human crystalline lens in adult and elderly persons: color and total transmission of visible light. Invest Ophthalmol Vis Sci 53:4076–4084CrossRefPubMed
51.
go back to reference Zagers NP, Pot MC, van Norren D (2005) Spectral and directional reflectance of the fovea in diabetes mellitus: photoreceptor integrity, macular pigment and lens. Vision Res 45:1745–1753CrossRefPubMed Zagers NP, Pot MC, van Norren D (2005) Spectral and directional reflectance of the fovea in diabetes mellitus: photoreceptor integrity, macular pigment and lens. Vision Res 45:1745–1753CrossRefPubMed
52.
go back to reference Krohne TU, Fauser S, Kirchhof B, Joussen AM (2003) Entstehungsmechanismen des diabetischen Makulaödems. Klin Monatsbl Augenheilkd 220:521–525CrossRefPubMed Krohne TU, Fauser S, Kirchhof B, Joussen AM (2003) Entstehungsmechanismen des diabetischen Makulaödems. Klin Monatsbl Augenheilkd 220:521–525CrossRefPubMed
53.
go back to reference Moreno A, Lozano M, Salinas P (2013) Diabetic retinopathy. Nutr Hosp 28(Suppl 2):53–56PubMed Moreno A, Lozano M, Salinas P (2013) Diabetic retinopathy. Nutr Hosp 28(Suppl 2):53–56PubMed
Metadata
Title
Influence of macular oedema on the measurement of macular pigment optical density
Authors
Simone Thiele
Franziska Georgia Rauscher
Peter Wiedemann
Jens Dawczynski
Publication date
01-03-2016
Publisher
Springer Berlin Heidelberg
Published in
Graefe's Archive for Clinical and Experimental Ophthalmology / Issue 3/2016
Print ISSN: 0721-832X
Electronic ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-015-3079-y

Other articles of this Issue 3/2016

Graefe's Archive for Clinical and Experimental Ophthalmology 3/2016 Go to the issue